The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Acceleration of α-Synuclein Aggregation by Exosomes
Open accessAbstract
Exosomes are small vesicles released from cells into extracellular space. We have isolated exosomes from neuroblastoma cells and investigated their influence on the aggregation of α-synuclein, a protein associated with Parkinson disease pathology. Using cryo-transmission electron microscopy of exosomes, we found spherical unilamellar vesicles with a significant protein content, and Western blot analysis revealed that they contain, as expected, the proteins Flotillin-1 and Alix. Using thioflavin T fluorescence to monitor aggregation kinetics, we found that exosomes catalyze the process in a similar manner as a low concentration of preformed α-synuclein fibrils. The exosomes reduce the lag time indicating that they provide catalytic environments for nucleation. The catalytic effects of exosomes derived from naive cells and cells that overexpress α-synuclein do not differ. Vesicles prepared from extracted exosome lipids accelerate aggregation, suggesting that the lipids in exosomes are sufficient for the catalytic effect to arise. Using mass spectrometry, we found several phospholipid classes in the exosomes, including phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, phosphatidylinositol, and the gangliosides GM2 and GM3. Within each class, several species with different acyl chains were identified. We then prepared vesicles from corresponding pure lipids or defined mixtures, most of which were found to retard α-synuclein aggregation. As a striking exception, vesicles containing ganglioside lipids GM1 or GM3 accelerate the process. Understanding how α-synuclein interacts with biological membranes to promote neurological disease might lead to the identification of novel therapeutic targets. Background: Cell-to-cell transmission of α-syn via exosomes has been proposed to propagate Parkinson disease pathology. Results: Exosomes contain gangliosides, several other lipid classes, and proteins. Exosomes and ganglioside vesicles accelerate α-syn aggregation. Vesicles made of other membrane lipids do not. Conclusion: Exosomes provide catalytic environments for nucleation of α-syn aggregation. Significance: Revealing factors that promote α-syn aggregation may provide insight into Parkinson disease pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Rouser, G., Fleischer, S., & Yamamoto, A. (1970) · Lipids · doi:10.1007/bf02531316 · Cited by 3,274
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
Biancalana, M., & Koide, S. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.04.001 · Cited by 2,195
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
Self-citationα-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Bartels, T., Choi, J. G., & Selkoe, D. J. (2011) · Nature · doi:10.1038/nature10324 · Cited by 1,263 · cited 1×
“-syn has been suggested to exist in a tetrameric state in vivo, although the relevance and existence of this form is debated (46, 47).”
BackgroundEmmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · cited 1×
“Secretion of -syn via exosomes has been proposed to amplify and propagate PD pathology (27–31), and several studies have identified -syn associated with exosomes (27, 32, 33).”
BackgroundEvidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010907200 · Cited by 1,096
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,080
Exosomes: secreted vesicles and intercellular communications
Théry, C. (2011) · F1000 Biology Reports · doi:10.3410/b3-15 · Cited by 989
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, A., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 911
Nucleation of protein fibrillation by nanoparticles
Linse, S., Cabaleiro-Lago, C., Xue, W.-F., Lynch, I., Lindman, S., Thulin, E., Radford, S. E., & Dawson, K. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701250104 · Cited by 886
Self-citationExosomal cell-to-cell transmission of alpha synuclein oligomers
Danzer, K. M., Kranich, L. R., Ruf, W. P., Cagsal-Getkin, O., Winslow, A. R., Zhu, L., Vanderburg, C. R., & McLean, P. J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-42 · Cited by 853
Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
Self-citationMurphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
Structure of Fully Hydrated Fluid Phase Lipid Bilayers with Monounsaturated Chains
Kučerka, N., Tristram-Nagle, S., & Nagle, J. F. (2006) · Journal of Membrane Biology · doi:10.1007/s00232-005-7006-8 · Cited by 801
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J. A., & Cooper, J. M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.029 · Cited by 748
Svensson, K. J., Christianson, H. C., Wittrup, A., Bourseau-Guilmain, E., Lindqvist, E., Svensson, L. M., Mörgelin, M., & Belting, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445403 · Cited by 688
Buell, A. K., Galvagnion, C., Gaspar, R., Sparr, E., Vendruscolo, M., Knowles, T. P. J., Linse, S., & Dobson, C. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315346111 · Cited by 664
Self-citationThe complex life of simple sphingolipids
Futerman, A. H., & Hannun, Y. A. (2004) · EMBO reports · doi:10.1038/sj.embor.7400208 · Cited by 659
Nakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L., Zhang, J., Gardner, B., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 596
Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Uversky, V. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04764.x · Cited by 567
Fauvet, B., Mbefo, M. K., Fares, M.-B., Desobry, C., Michael, S., Ardah, M. T., Tsika, E., Coune, P., Prudent, M., Lion, N., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.318949 · Cited by 566
GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease
Yanagisawa, K., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Nature Medicine · doi:10.1038/nm1095-1062 · Cited by 550
A Broken α-Helix in Folded α-Synuclein
Chandra, S., Chen, X., Rizo, J., Jahn, R., & Südhof, T. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213128200 · Cited by 540
Wakabayashi, K., Tanji, K., Mori, F., & Takahashi, H. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00803.x · Cited by 516
Meisl, G., Yang, X., Hellstrand, E., Frohm, B., Kirkegaard, J. B., Cohen, S. I. A., Dobson, C. M., Linse, S., & Knowles, T. P. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401564111 · Cited by 505
Self-citationProton-powered turbine of a plant motor
Seelert, H., Poetsch, A., Dencher, N. A., Engel, A., Stahlberg, H., & Müller, D. J. (2000) · Nature · doi:10.1038/35013148 · Cited by 465
Neuropathology underlying clinical variability in patients with synucleinopathies
Halliday, G. M., Holton, J. L., Revesz, T., & Dickson, D. W. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0852-9 · Cited by 430
Bussell, R., & Eliezer, D. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00520-5 · Cited by 418
Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?
Bellingham, S. A., Guo, B. B., Coleman, B. M., & Hill, A. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00124 · Cited by 412
Kakio, A., Nishimoto, S.-I., Yanagisawa, K., Kozutsumi, Y., & Matsuzaki, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100252200 · Cited by 406
Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405
Hellstrand, E., Boland, B., Walsh, D. M., & Linse, S. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn900015v · Cited by 392
Self-citationEffects of Curvature and Composition on α-Synuclein Binding to Lipid Vesicles
Middleton, E. R., & Rhoades, E. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.07.056 · Cited by 376
Lysosomal impairment in Parkinson's disease
Dehay, B., Martinez‐Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., Klein, C., Vila, M., & Bezard, E. (2013) · Movement Disorders · doi:10.1002/mds.25462 · Cited by 340
Ariga, T., McDonald, M. P., & Yu, R. K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800007-jlr200 · Cited by 318
Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid β Protein Fibrillation
Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Dawson, K. A., & Linse, S. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn900027u · Cited by 275
Self-citationScott, C. C., & Gruenberg, J. (2011) · BioEssays · doi:10.1002/bies.201000108 · Cited by 271
GM1 Specifically Interacts with α-Synuclein and Inhibits Fibrillation
Martinez, Z., Zhu, M., Han, S., & Fink, A. L. (2007) · Biochemistry · doi:10.1021/bi061749a · Cited by 260
Are synucleinopathies prion-like disorders?
Angot, E., Steiner, J. A., Hansen, C., Li, J.-Y., & Brundin, P. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70213-1 · Cited by 251
Self-citationNeurobiology and treatment of Parkinson's disease
Schapira, A. H. V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.005 · Cited by 247
Ejlerskov, P., Rasmussen, I., Nielsen, T. T., Bergström, A.-L., Tohyama, Y., Jensen, P. H., & Vilhardt, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401174 · Cited by 236
Emerging Role of Neuronal Exosomes in the Central Nervous System
Chivet, M., Hemming, F., Pernet-Gallay, K., Fraboulet, S., & Sadoul, R. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00145 · Cited by 223
Aβ polymerization through interaction with membrane gangliosides
Matsuzaki, K., Kato, K., & Yanagisawa, K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.008 · Cited by 222
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H., Cartwright, M. I., Griffiths, F. M., Shepherd, C. E., & Double, K. L. (2005) · Brain · doi:10.1093/brain/awh584 · Cited by 219
Hong, S., Ostaszewski, B. L., Yang, T., O’Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., & Selkoe, D. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.027 · Cited by 213
α-Synuclein Binds Large Unilamellar Vesicles as an Extended Helix
Trexler, A. J., & Rhoades, E. (2009) · Biochemistry · doi:10.1021/bi900114z · Cited by 212
Mitochondrial translocation of α-synuclein is promoted by intracellular acidification
Cole, N. B., DiEuliis, D., Leo, P., Mitchell, D. C., & Nussbaum, R. L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.012 · Cited by 185
α-Synuclein Selectively Binds to Anionic Phospholipids Embedded in Liquid-Disordered Domains
Stöckl, M., Fischer, P., Wanker, E., & Herrmann, A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.051 · Cited by 178
Strategies to increase the reproducibility of protein fibrillization in plate reader assays
Giehm, L., & Otzen, D. E. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.02.001 · Cited by 177
Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology
Michel, C. H., Kumar, S., Pinotsi, D., Tunnacliffe, A., St. George-Hyslop, P., Mandelkow, E., Mandelkow, E.-M., Kaminski, C. F., & Kaminski Schierle, G. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515445 · Cited by 165
Exosomes of BV-2 cells induced by alpha-synuclein: Important mediator of neurodegeneration in PD
Chang, C., Lang, H., Geng, N., Wang, J., Li, N., & Wang, X. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.009 · Cited by 163
Snaring the Function of α-Synuclein
Bonini, N. M., & Giasson, B. I. (2005) · Cell · doi:10.1016/j.cell.2005.10.017 · Cited by 162
Improved Immunodetection of Endogenous α-Synuclein
Lee, B. R., & Kamitani, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023939 · Cited by 158
Exosomes as a novel way of interneuronal communication
Chivet, M., Javalet, C., Hemming, F. J., Pernet‐Gallay, K., Laulagnier, K., Fraboulet, S., & Sadoul, R. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120266 · Cited by 146
Membrane Interaction of α-Synuclein in Different Aggregation States
Grey, M., Linse, S. S., Nilsson, H., Brundin, P., & Sparr, E. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11067 · Cited by 140
Self-citationGraham, J., & SAGAR, H. J. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<10::aid-mds1005>3.0.co;2-4 · Cited by 140
Arosio, P., Cukalevski, R., Frohm, B., Knowles, T. P. J., & Linse, S. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408765u · Cited by 125
Self-citationMembrane Lipid Co-Aggregation with α-Synuclein Fibrils
Hellstrand, E., Nowacka, A., Topgaard, D., Linse, S. S., & Sparr, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077235 · Cited by 123
Self-citationCan Parkinson's disease pathology be propagated from one neuron to another?
Dunning, C. J. R., Reyes, J. F., Steiner, J. A., & Brundin, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.11.003 · Cited by 121
Self-citationOkada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., & Matsuzaki, K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.072 · Cited by 118
Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
Vingtdeux, V., Sergeant, N., & Buée, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00229 · Cited by 116
Adsorption of α-Synuclein to Supported Lipid Bilayers: Positioning and Role of Electrostatics
Hellstrand, E., Grey, M., Ainalem, M.-L., Ankner, J. F., Forsyth, V. T., Fragneto, G., Haertlein, M., Dauvergne, M.-T., Nilsson, H., Brundin, P., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400066t · Cited by 105
Self-citationIonization Constants pKa of Cardiolipin
Olofsson, G., & Sparr, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073040 · Cited by 105
Self-citationKeilani, S., Lun, Y., Stevens, A. C., Williams, H. N., Sjoberg, E. R., Khanna, R., Valenzano, K. J., Checler, F., Buxbaum, J. D., Yanagisawa, K., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4860-11.2012 · Cited by 100
Dielectric properties of blood: an investigation of haematocrit dependence
Jaspard, F., Nadi, M., & Rouane, A. (2003) · Physiological Measurement · doi:10.1088/0967-3334/24/1/310 · Cited by 98
Depth of α-Synuclein in a Bilayer Determined by Fluorescence, Neutron Reflectometry, and Computation
Pfefferkorn, C. M., Heinrich, F., Sodt, A. J., Maltsev, A. S., Pastor, R. W., & Lee, J. C. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2011.12.051 · Cited by 97
Lysosomal dysfunction in Parkinson disease
Dehay, B., Martínez‐Vicente, M., Ramı́rez, A., Perier, C., Klein, C., Vila, M., & Bézard, E. (2012) · Autophagy · doi:10.4161/auto.21011 · Cited by 88
Hoshino, T., Mahmood, M. I., Mori, K., & Matsuzaki, K. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4029062 · Cited by 83
Lipid matrix plays a role in Abeta fibril kinetics and morphology
Sani, M., Gehman, J. D., & Separovic, F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.011 · Cited by 81
Dunning, C. J. R., George, S., & Brundin, P. (2013) · Prion · doi:10.4161/pri.23806 · Cited by 77
Self-citationRabe, M., Soragni, A., Reynolds, N. P., Verdes, D., Liverani, E., Riek, R., & Seeger, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3001312 · Cited by 75
Robotta, M., Braun, P., van Rooijen, B. D., Subramaniam, V., Huber, M., & Drescher, M. (2010) · ChemPhysChem · doi:10.1002/cphc.201000815 · Cited by 69
Lewy bodies in Parkinson's disease: Protectors or perpetrators?
Harrower, T., Michell, A. W., & Barker, R. A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.002 · Cited by 31
Resistance of naturally secreted α‐synuclein to proteolysis
Ximerakis, M., Pampalakis, G., Roumeliotis, T. I., Sykioti, V. S., Garbis, S. D., Stefanis, L., Sotiropoulou, G., & Vekrellis, K. (2014) · The FASEB Journal · doi:10.1096/fj.13-245852 · Cited by 20
Cited by
Therapeutically harnessing extracellular vesicles
Cheng, L., & Hill, A. F. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00410-w · Cited by 737
Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
Thompson, A. G., Gray, E., Heman-Ackah, S. M., Mäger, I., Talbot, K., Andaloussi, S. E., Wood, M. J., & Turner, M. R. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.68 · Cited by 431
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Extracellular vesicles: novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos, D., Albuquerque, P. R., Carmona, V., Perfeito, R., Nobre, R. J., & Pereira de Almeida, L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.001 · Cited by 418
Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy
Liao, W., Du, Y., Zhang, C., Pan, F., Yao, Y., Zhang, T., & Peng, Q. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.045 · Cited by 411
Metadata
- Authors
- Grey, M., Dunning, C. J., Gaspar, R., Grey, C., Brundin, P., Sparr, E., & Linse, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 290
- Issue
- 5
- Pages
- 2969-2982
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2115923704
- Cited by
- 377
- References
- 85
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.